David Bejker

David Bejker

Director/Board Member at ABLIVA AB
51 year
Health Technology
Finance
Consumer Services

Profile

David Bejker is currently Chief Executive Officer at Affibody Medical AB since 2018.
Mr. Bejker is an Independent Director at Abliva AB since 2017.
Mr. Bejker is a Director at Amylonix AB. Mr. Bejker is a Director at Disruptive Pharma Holding AB. Mr. Bejker is an Independent Non-Executive Director at Disruptive Pharma AB since 2023.
Former positions include Chief Executive Officer & Director at Affibody AB from 2003 to 2005, Deputy Director at Nexstim Oyj, Independent Director at LIDDS AB, and Principal at HealthCap AB. Education includes graduation from Stockholm School of Economics.

David Bejker active positions

CompaniesPositionStart
ABLIVA AB Director/Board Member 26/04/2017
Chief Executive Officer 30/11/2018
Director/Board Member -
Disruptive Pharma Holding AB
Director/Board Member -

Former positions of David Bejker

CompaniesPositionEnd
Chief Executive Officer 30/06/2005
LIDDS AB Director/Board Member -
NEXSTIM PLC Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of David Bejker's experience

Training of David Bejker

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

35

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Disruptive Pharma Holding AB